Literature DB >> 12717066

Estimation of fractional liver uptake and blood retention of 99mTc-DTPA-galactosyl human serum albumin: an application of a simple graphical method to dynamic SPECT.

N Shuke1, T Aburano, A Okizaki, C Zhao, K Nakajima, K Yokoyama, S Kinuya, N Watanabe, T Michigishi, N Tonami.   

Abstract

The objective of this study was to investigate clinical utility of a graphical method for estimating liver uptake and blood retention of 99mTc-DTPA-galactosyl human serum albumin (99mTc-GSA; DTPA is diethylenetriaminepentaacetic acid) using dynamic single photon emission computed tomography (SPECT) data. When considering the kinetics of 99mTc-GSA, if it is assumed that (1) 99mTc-GSA distributes only between blood and liver, and (2) no metabolism of 99mTc-GSA occurs during the observation period, a plot of liver counts versus cardiac blood pool counts should, theoretically, be a straight line. From the slope and y intercept of a regression line, coefficients for converting count based liver and blood pool data to the per cent injected dose (%ID) can be calculated. The applicability of this method was tested on dynamic SPECT data from 30 patients with liver dysfunction. To validate this method, plasma concentrations (%ID/ml plasma) at 6, 15 and 30 min after the injection were estimated by this method and compared with the measured ones. To investigate the clinical significance of the per cent liver uptake, the value obtained by this method was compared with the results of conventional liver function tests, including serum albumin, the hepaplastin test, prothrombin time and indocyanine green clearance. In every data set, a plot of liver counts to cardiac blood pool counts was fitted well by a straight line (P<0.00001). Estimated plasma concentrations by this method showed good correlation with the measured ones at 6, 15 and 30 min after the injection (r=0.748, 0.838, 0.875, respectively; P<0.0001). The liver uptake determined by this method showed good correlation with the results of conventional hepatic function tests (P<0.002). The graphical method could provide an accurate estimate of %ID of 99mTc-GSA in blood without the need for blood sampling. The liver uptake determined by this method could be a simple but useful quantitative indicator of hepatic function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717066     DOI: 10.1097/00006231-200305000-00004

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  3 in total

1.  Hepatic clearance measured with (99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis.

Authors:  Masahiko Taniguchi; Atsutaka Okizaki; Kenji Watanabe; Koji Imai; Koichiro Uchida; Takahiro Einama; Noriyuki Shuke; Naoyuki Miyokawa; Hiroyuki Furukawa
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

2.  Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors.

Authors:  Kana Yamazaki; Ryuichi Nishii; Yoichi Mizutani; Hirokazu Makishima; Takashi Kaneko; Yoshiharu Isobe; Tamasa Terada; Kentaro Tamura; Etsuko Imabayashi; Toshiaki Tani; Masato Kobayashi; Masaru Wakatsuki; Hiroshi Tsuji; Tatsuya Higashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10-04       Impact factor: 10.057

Review 3.  Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.

Authors:  Liang Wang
Journal:  Hepat Med       Date:  2010-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.